Nasdaq News

Key PointsPalantir has emerged as the gold standard in enterprise artificial intelligence due to its unique software architecture.

Key PointsMarket valuation metrics and margin debt levels are at historically high levels.

October NY world sugar #11 (SBV26 ) is up +0.46 (+2.63%) today, and December London ICE white sugar #5 (SWZ26 ) is up +7.40 (+1.47%). Sugar prices are moving higher today, with London sugar posting a 1-week high. Prices are trading sideways within a wide month-long range, between last Tuesday’s...

(RTTNews) - Mayne Pharma Group Ltd. (MYX.AX) announced that Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS) has agreed to settle U.S. Paragraph IV patent litigation concerning IMVEXXY and its associated FDA Orange Book-listed patents.

(RTTNews) - On Tuesday, Argenx SE (ARGX) announced that it will present new clinical, long-term and real-world data for VYVGART (efgartigimod) across Myasthenia gravis and Chronic inflammatory demyelinating polyneuropathy (CIDP), along with updates from its neuromuscular pipeline

Key PointsWalmart and WM operate businesses that consumers consistently need.

Key PointsNadella turned around Microsoft by focusing on enterprise cloud solutions in both software and compute.

Key PointsThe S&P 500 is on pace for its fourth consecutive year of double-digit gains amid strong financial results driven by heavy spending on AI.

Key PointsIt’s been a year of historic change at the nation’s central bank, with new Fed Chair Kevin Warsh kicking off only the fourth rate-hiking cycle of the 21st century on Sept. 16.

(RTTNews) - Zealand Pharma A/S (ZEAL.CO), a biotechnology company, on Wednesday announced the publication of new results from the Phase 3 ZUPREME-1 trial for Petrelintide in weight management. The data was published in The Lancet Diabetes and Endocrinology journal.

Fintel reports that on September 29, 2026, Scotiabank initiated coverage of Xcel Energy Inc. - Preferred Stock (NASDAQGM:XELLL) with a Sector Outperform recommendation. On the day of the coverage initiation, September 29, 2026, the stock's latest close was $20.96. This followed a

Key PointsBroadcom's fourth-quarter gains since 2013 ran from under 3% to around 37%.

Key PointsMuse could be a major catalyst for Shopify, giving new merchants another reason to choose the platform.

(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK, 4502.T) announced new data from three Phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279) in adults with moderate-to-severe plaque psoriasis.

(RTTNews) - Roche Holding AG (RHHBY), a healthcare company, announced two regulatory developments, with the U.S. FDA accepting its New Drug Application (NDA) for Fenebrutinib in relapsing multiple sclerosis and primary progressive multiple sclerosis under Priority Review.

(RTTNews) - AbbVie (ABBV) announced positive interim results from the Phase 2 APEX Part B dose-regimen-finding Study of zumilokibart in adult patients with moderate to severe atopic dermatitis, supporting further development of the investigational therapy.

Key PointsOracle's rising bond yields have raised concerns about how the AI build-out will be financed moving forward.

(RTTNews) - A strong positive sentiment is expected to prevail in European stock markets on Wednesday amidst a sharp decline in Fed rate hike expectations. The decline in crude oil prices, the easing in bond yields and the dollar's retreat are also expected to bolster sentiment.

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW) announced Wednesday the launch of newborn screening test for three severe genetic conditions, such as Spinal Muscular Atrophy or SMA, Severe Combined Immunodeficiency Disease or SCID, and Sickle Cell Disease or

(RTTNews) - TomTom N.V. (TOM2.AS), a location technology specialist, Wednesday announced its expanded collaboration with major global technology company, Microsoft (MSFT), bringing TomTom's location intelligence to AI agents built on Microsoft Fabric and Microsoft Foundry through